Hairy cell leukemia (HCL) is a rare form of cancer. It involves white blood cells called B lymphocytes. White blood cells protect the body from infection. HCL gets its name from the tiny hair-like projections that stick out of the surface of these cancer cells. Illness results from the buildup of these cancer cells in the bone marrow and spleen.
Cancer occurs when cells in the body become abnormal. They divide without control or order. Leukemia is cancer of the white blood cells and their parent cells. Leukemia cells do not function normally. In this case, they can not fight infections. This means that the person is more likely to become infected with viruses or bacteria. The cancerous cells also overgrow the bone marrow. This forces other normal cells, like platelets out. Platelets are needed to help the blood clot. As a result, people with leukemia may bleed more easily.
The exact cause of HCL is unknown, but it may be linked to a genetic mutation.
HCL is a slow-growing cancer. As HCL progresses, treatment may include:
may need to be done to remove an enlarged spleen.
is the use of drugs to kill cancer cells. It may be given in many forms. This includes pill, injection, and through an IV. The drugs enter the bloodstream and travel through the body.
Medications, such as cladribine, pentostatin, and interferon, are used to fight the hairy cells.
General information about hairy cell leukemia treatment. National Cancer Institute website. Available at:
Updated April 6, 2016. Accessed January 8, 2018.
Hairy cell leukemia. Leukemia & Lymphoma Society website. Available at: ...(Click grey area to select URL) Accessed January 8, 2018.
Treating hairy cell leukemia. American Cancer Society website. Available at: https://www.cancer.org/cancer/chronic-lymphocytic-leukemia/treating/hairy-cell-leukemia.html. Updated April 11, 2016. Accessed January 8, 2018.